Fundamentals data is not available for this company.
No recent information was found.
Patents Ending, Eli Lilly Chases New Drugs | 01-Oct-2010 | New York Times |
Lilly aborts inhaled insulin plans | 08-Mar-2008 | LA Times |
Lilly Ends Effort to Develop an Inhaled Insulin ... | 08-Mar-2008 | New York Times |
Currency | US Dollars |
Share Price | $ 29.27 |
Change Today | $ 0.21 |
% Change | 0.72 % |
52 Week High | $36.00 |
52 Week Low | $25.70 |
Volume | 8,181 |
Shares Issued | 156.88m |
Market Cap | $4,591.95m |
Beta | 0.21 |
RiskGrade | 248 |
Time | Volume / Share Price |
09:34 | 100 @ $29.27 |
09:34 | 142 @ $29.29 |
09:34 | 100 @ $29.29 |
09:34 | 100 @ $29.29 |
09:34 | 100 @ $29.30 |
You are here: research